Definium Therapeutics Inc. Common Shares vs Frontline Plc Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B), while Frontline Plc Ordinary Shares trades at $56.06 (market cap $12.52B). The key difference: Frontline Plc Ordinary Shares is far larger — about 2.7× Definium Therapeutics Inc. Common Shares's market cap, and Frontline Plc Ordinary Shares pays a 9.56% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Frontline Plc Ordinary Shares for 0 Days on average.
| DFTX | FRO | |
|---|---|---|
Market Cap | $4.59B | $12.52B |
Volume | 2,103,937 | 6,375,509 |
Sector | Health | Industrials |
52-Week High | $48.45 | $56.26 |
52-Week Low | $10.68 | $20.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $14.64B |
Dividend Yield | — | 9.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.
Read more on FRO →